HAE
Haemonetics Corp
Price:  
91.06 
USD
Volume:  
296,374.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HAE WACC - Weighted Average Cost of Capital

The WACC of Haemonetics Corp (HAE) is 7.1%.

The Cost of Equity of Haemonetics Corp (HAE) is 7.75%.
The Cost of Debt of Haemonetics Corp (HAE) is 4.35%.

Range Selected
Cost of equity 6.30% - 9.20% 7.75%
Tax rate 15.90% - 20.10% 18.00%
Cost of debt 4.00% - 4.70% 4.35%
WACC 5.9% - 8.4% 7.1%
WACC

HAE WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.53 0.78
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.30% 9.20%
Tax rate 15.90% 20.10%
Debt/Equity ratio 0.18 0.18
Cost of debt 4.00% 4.70%
After-tax WACC 5.9% 8.4%
Selected WACC 7.1%